Research summary, original research, 2018

Fluoroscopy integrating technology in a 3D mapping system during ablation of atrial arrhythmias: first experiences

Blockhaus C, Schmidt J, Kurt M, Clasen L, Müller P, Brinkmeyer C, et al.. Archives of medical science : AMS. 2018

Read the original paper

In plain language

In 59 atrial ablation patients at one centre, adding a fluoroscopy-integrating module to 3D mapping lowered fluoroscopy time and dose-area product by roughly a third to a half without lengthening procedures. Staff dose was not measured directly.

At a glance

Type of study
Original research, Retrospective cohort study
Who was studied
Patients, Electrophysiologists
Size
n = 59 patients
Summary based on
the full text

What it found

  • In pulmonary vein isolation (PVI), the fluoroscopy integrating system (FIS) reduced dose-area product after a short learning curve.

    Key figures: 801.9 ±439.15 cGycm² vs. 1495 ±435.2 cGycm², p = 0.002

  • In PVI, fluoroscopy time was reduced with FIS.

    Key figures: 361.6 ±181 s vs. 530.3 ±156.7 s, p = 0.039

  • In CTI ablation for atrial flutter, FIS roughly halved dose-area product (DAP) and reduced fluoroscopy time.

    Key figures: DAP 269 ±128.7 vs. 524.3 ±288.4 cGycm², p = 0.002; FT 99.29 ±51.4 s vs. 153.9 ±76.6 s, p = 0.022

  • Procedure time was not significantly changed with FIS.

    Key figures: PVI 121 ±26.7 vs. 135.6 ±23.2 min, p = 0.21; CTI 29.5 ±10 vs. 35.2 ±16.3 min, p = 0.23

  • Fluoroscopy before transseptal puncture or catheter placement was not reduced, since FIS only works once catheters are in the heart.

Limits to keep in mind

Small single-centre study with retrospective historical controls and one operator for PVI; the first 6 FIS cases were excluded. Only patient-side metrics (FT, DAP) were recorded; staff dose was not measured.

How this summary was made

ORSIF prepared this summary with AI assistance from the full text of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.